Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Research Tools and Instruments - Category 1 (<$150,000)

University of Toronto

$139,739.00

Ultrasonic (US) imager for enhanced resolution, contrast and fast patient screening via co-registration with photoacoustic-radar tomographic (PART) imaging of breast cancer

EF 2010-11

Résumé
A biomedical ultrasonic (US) imager is requested as an accessory to, and for integration and co-registration (or co-imaging) with, a unique photoacoustic-radar tomography (PART) imager developed in our laboratory. The PART imager operates in the frequency domain, it uses current-modulated semiconductor laser sources and a transducer phased array with detection based on radar (or sonar) principles. PART software produces simultaneous amplitude and phase images. The proposed combination of the two imaging modalities (PART - US) for early breast cancer diagnostic applications will be superior to PART imaging alone and to US imaging alone on many important counts: 1) Conventional ultrasound is a mature technology and co-registration can greatly facilitate the integration of our novel PART imaging modality into a commercial system, where photoacoustic and ultrasonic excitation sources will be using the same ultrasonic receiver array; 2) the ultrasound channel can be used for quick screening and identification of biological tissue targets therefore paving the way for real-time PART - US clinical imaging; 3) the co-registered superposition image can exhibit superior specificity by highlighting the presence of blood (in the case of angiogenetic tumors) for better visualization of tumor morphology and location among other contrasting - and possibly confusing- stray signals obtained by each modality alone due to acoustic scatterers and boundary reflections at the surrounding anatomy; 4) using a two-wavelength PART source under development in our system, the relative amplitude strengths of images at the two near-infrared wavelengths will be used to assess the degree of blood oxygenation of ultrasonically delineated tumors, thereby establishing a malignant / benign tumor diagnosis criterion.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
407872-2011
Name nom
Mandelis, Andreas
Department département
Mechanical and Industrial Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2011
Award amount
139739
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Ultrasonic (US) imager for enhanced resolution, contrast and fast patient screening via co-registration with photoacoustic-radar tomographic (PART) imaging of breast cancer
Keyword
NSERC
Application summary
A biomedical ultrasonic (US) imager is requested as an accessory to, and for integration and co-registration (or co-imaging) with, a unique photoacoustic-radar tomography (PART) imager developed in our laboratory. The PART imager operates in the frequency domain, it uses current-modulated semiconductor laser sources and a transducer phased array with detection based on radar (or sonar) principles. PART software produces simultaneous amplitude and phase images. The proposed combination of the two imaging modalities (PART - US) for early breast cancer diagnostic applications will be superior to PART imaging alone and to US imaging alone on many important counts: 1) Conventional ultrasound is a mature technology and co-registration can greatly facilitate the integration of our novel PART imaging modality into a commercial system, where photoacoustic and ultrasonic excitation sources will be using the same ultrasonic receiver array; 2) the ultrasound channel can be used for quick screening and identification of biological tissue targets therefore paving the way for real-time PART - US clinical imaging; 3) the co-registered superposition image can exhibit superior specificity by highlighting the presence of blood (in the case of angiogenetic tumors) for better visualization of tumor morphology and location among other contrasting - and possibly confusing- stray signals obtained by each modality alone due to acoustic scatterers and boundary reflections at the surrounding anatomy; 4) using a two-wavelength PART source under development in our system, the relative amplitude strengths of images at the two near-infrared wavelengths will be used to assess the degree of blood oxygenation of ultrasonically delineated tumors, thereby establishing a malignant / benign tumor diagnosis criterion.